We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.87%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.81B
AUM Growth
-$531M
(-9.9%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-25.85%
Top 10 Holdings %
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256
Avg Time Held Equity + Options
0.6
quarters
Top 10 Avg Time Held Equity + Options
0.6
quarters
Top 20 Avg Time Held Equity + Options
0.4
quarters
Avg Time Held Equity only
0.6
quarters
Top 10 Avg Time Held Equity only
0.6
quarters
Top 20 Avg Time Held Equity only
0.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$59.4M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$56.3M |
| 3 |
Simon Property Group
SPG
|
+$52M |
| 4 |
TSMC
TSM
|
+$45.4M |
| 5 |
Macy's
M
|
+$44.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$167M |
| 2 |
GDI
GARDNER DENVER,INC
GDI
|
+$60.4M |
| 3 |
BMC
BMC SOFTWARE, INC
BMC
|
+$58.7M |
| 4 |
SMITHFIELD FOODS,INC
SFD
|
+$55.2M |
| 5 |
Advance Auto Parts
AAP
|
+$48.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.53% |
| 2 | Real Estate | 16.41% |
| 3 | Consumer Staples | 12.46% |
| 4 | Financials | 6.75% |
| 5 | Consumer Discretionary | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
Best Buy
BBY
$18.1B
| – | – |
-289,645
| Closed | -$7.92M | – |
|
|
377
PUT
Best Buy
BBY
$18.1B
| – | – |
-1,000,000
| Closed | -$45K | – |
|
378
Biogen
BIIB
$34.5B
| – | – |
-36,000
| Closed | -$7.75M | – |
|
379
PUT
Bank of New York Mellon
BNY
$97B
| – | – |
-125,000
| Closed | -$90K | – |
|
380
BioMarin Pharmaceuticals
BMRN
$10.7B
| – | – |
-47,000
| Closed | -$2.62M | – |
|
381
Bristol-Myers Squibb
BMY
$117B
| – | – |
-107,000
| Closed | -$4.78M | – |
|
382
Brady Corp
BRC
$4.01B
| – | – |
-51,972
| Closed | -$1.6M | – |
|
383
Conagra Brands
CAG
$6.49B
| – | – |
-1,294,639
| Closed | -$35.2M | – |
|
384
PUT
Caterpillar
CAT
$372B
| – | – |
-115,000
| Closed | -$300K | – |
|
385
COPT Defense Properties
CDP
$3.82B
| – | – |
-421,676
| Closed | -$10.8M | – |
|
386
CF Industries
CF
$17.2B
| – | – |
-98,230
| Closed | -$3.37M | – |
|
387
Cigna
CI
$74.7B
| – | – |
-103,583
| Closed | -$7.51M | – |
|
388
Chimera Investment
CIM
$736M
| – | – |
-107,170
| Closed | -$4.82M | – |
|
389
PUT
Clorox
CLX
$10.1B
| – | – |
-300,000
| Closed | -$545K | – |
|
390
PUT
DELISTED
Comerica
CMA
| – | – |
-250,000
| Closed | -$239K | – |
|
391
Comcast
CMCSA
$73.1B
| – | – |
-100,000
| Closed | -$2.09M | – |
|
392
Centene
CNC
$32.7B
| – | – |
-80,000
| Closed | -$1.05M | – |
|
393
Capital One
COF
$123B
| – | – |
-401,254
| Closed | -$25.2M | – |
|
394
Costco
COST
$423B
| – | – |
-352,264
| Closed | -$39M | – |
|
395
Canadian Pacific Kansas City
CP
$74.7B
| – | – |
-421,405
| Closed | -$10.2M | – |
|
396
CALL
Campbell Soup
CPB
$5.7B
| – | – |
-100,000
| Closed | -$20K | – |
|
397
Cisco
CSCO
$451B
| – | – |
-125,000
| Closed | -$3.04M | – |
|
398
CALL
Cognizant
CTSH
$26.9B
| – | – |
-196,400
| Closed | -$73K | – |
|
399
Community Health Systems
CYH
$402M
| – | – |
-24,200
| Closed | -$938K | – |
|
400
Dana Inc
DAN
$3.11B
| – | – |
-209,627
| Closed | -$4.04M | – |
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q3 2013 Portfolio in Review
As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS O'Connor withdrew a net $1.24B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 27% a quarter earlier, followed by Real Estate and Consumer Staples.
Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.
- UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
- UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
- UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
- UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
- UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
- UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
- UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.
Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.